Company / R&D per Share
Nutex Health, Inc. R&D per Share History
FY2018-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.05
FY2021
5-year range
$0.05 / $0.05
FY2018-FY2021
Trend
-54.8%
vs FY2020
Sector context
#161 of 164
Industrials
What the data says
Among 164 Industrials companies, Nutex Health, Inc. is in the bottom 2% for r&d per share. Declined from $0.99 to $0.05 over the past 2 years.
Based on SEC 10-K filings.
0.05 in FY2021 with a 3-year CAGR of -44.7%.
Declined from $0.99 to $0.05 over the past 2 years.
Industrials sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -44.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in IndustrialsTop 98% of 164This company $0.05 Sector average $1.80
▼
-97.0% below sector average
Key checks
Key Insights
- In FY2021, r&d per share decreased 54.8% year-over-year.
- Ranks #161 out of 164 companies in the Industrials sector.
Company context
Key Data Points
- Strong profit margin: 40.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0.05 | -54.8% |
| FY2020 | $0.12 | -87.9% |
| FY2019 | $0.99 | +208.6% |
| FY2018 | $0.32 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2021 · SEC 10-K · Updated Mar 28, 2026